fluocinonide NDC 0168-0134

NDC codes

FDA NDC Directory

Product NDC (as listed)0168-0134Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00168-0134Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0168-0134-60	00168013460	1 BOTTLE in 1 CARTON (0168-0134-60) / 60 mL in 1 BOTTLEMarketed from Feb 27, 1995

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): fluocinonide
Generic name (nonproprietary): fluocinonide
Active ingredients: Fluocinonide — .5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072934
Marketing start: Feb 27, 1995
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0168-0134_e2784b8c-ca35-4719-8fca-169ecc08b529SPL ID e2784b8c-ca35-4719-8fca-169ecc08b529SPL set ID ebca0c66-06f6-438a-a01a-634c53debc06RxCUI 310364UNII 2W4A77YPAN
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400168013460 followed by a unit qualifier and the quantity

Package 00168-0134-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Fluocinonide Topical Solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072934

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072934
Product	Strength	Form · route	Labeler	Product NDC
fluocinonide	Fluocinonide .5 mg/mL	SolutionTopical	Bryant Ranch Prepack	72162-2146